Yanping Ding
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Oncology top 2%
- CAR-T cell therapy research
Papers in
- Oncology 21
- CAR-T cell therapy research 10
- Peptidase Inhibition and Analysis 5
-
- RNA Interference and Gene Delivery 5
- Angiogenesis and VEGF in Cancer 5
- Co-authors
- Guangjun Nie (23 shared papers)Yoshimasa Tanaka (4 shared papers)Wen Zhang (3 shared papers)Tianjiao Ji (13 shared papers)Ying Zhao (11 shared papers)Yinlong Zhang (10 shared papers)Nan Song (8 shared papers)Xiao Zhao (7 shared papers)
- Journals
- ACS Nano (3 papers)Biomaterials (3 papers)Cancer Research (2 papers)Clinical Cancer Research (2 papers)Molecular Therapy — Oncolytics (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yanping Ding
73 papers receiving 4.9k citations
Yanping Ding's Hit Papers
Peers
Comparison fields: 5 of 152
- Biomaterials 1.0k
- Oncology 1.0k
- Cancer Research 515
- Immunology 749
- Biomedical Engineering 1.6k
Countries citing papers authored by Yanping Ding
This map shows the geographic impact of Yanping Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Ding more than expected).
Fields of papers citing papers by Yanping Ding
This network shows the impact of papers produced by Yanping Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Ding. The network helps show where Yanping Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanping Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention Hit paper breakdown → | 2014 | 906 |
| 2 | Field-Free Isolation of Exosomes from Extracellular Vesicles by Microfluidic Viscoelastic Flows Hit paper breakdown → | 2017 | 424 |
| 3 | 2018 | 292 | |
| 4 | 2015 | 200 | |
| 5 | 2009 | 190 | |
| 6 | 2011 | 186 | |
| 7 | 2015 | 174 | |
| 8 | 2013 | 169 | |
| 9 | 2017 | 156 | |
| 10 | 2019 | 144 | |
| 11 | 2018 | 144 | |
| 12 | 2016 | 131 | |
| 13 | 2015 | 128 | |
| 14 | 2019 | 119 | |
| 15 | 2014 | 119 | |
| 16 | 2016 | 107 | |
| 17 | 2009 | 102 | |
| 18 | 2012 | 96 | |
| 19 | 2015 | 90 | |
| 20 | 2016 | 89 |
About Yanping Ding
Yanping Ding is a scholar working on Oncology, Molecular Biology, Biomedical Engineering, Biomaterials and Immunology, having authored 73 papers that have together received 5.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (12 papers), CAR-T cell therapy research (10 papers), Electrocatalysts for Energy Conversion (8 papers), RNA Interference and Gene Delivery (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Peptidase Inhibition and Analysis (5 papers) and Fuel Cells and Related Materials (5 papers). The work is most often cited by research in Biomaterials (1.0k citations), Oncology (1.0k citations), Cancer Research (515 citations), Immunology (749 citations) and Biomedical Engineering (1.6k citations). Yanping Ding has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Guangjun Nie, Yoshimasa Tanaka, Wen Zhang, Tianjiao Ji, Ying Zhao, Yinlong Zhang, Nan Song, Xiao Zhao, Ruifang Zhao and Yujie Huang. Their work appears in journals such as ACS Nano, Biomaterials, Cancer Research, Clinical Cancer Research and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.